Literature DB >> 15987955

Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta.

Zachary C Baquet1, Paula C Bickford, Kevin R Jones.   

Abstract

Brain-derived neurotrophic factor (BDNF) has been implicated in regulating neuronal survival, differentiation, and synaptic plasticity. Reduced expression of BDNF within the substantia nigra accompanies the deterioration of dopaminergic neurons in Parkinson's disease (PD) patients. Analysis of the effects of long-term BDNF absence from the CNS has been difficult because of the early postnatal lethality of BDNF-/- mice. Mice with a floxed BDNF allele were bred with Wnt1-Cre mice to generate Wnt-BDNF(KO) mice that lack BDNF from the midbrain-hindbrain (MHB). These mice are viable but exhibit hindlimb clutching and poor rotarod performance. Tyrosine hydroxylase (TH)-positive neuron numbers in the substantia nigra pars compacta (SNC) were estimated using stereological methods, revealing a persistent approximately 23% reduction of these cells at postnatal day 21 (P21) in Wnt-BDNF(KO) mice compared with controls. The diminishment of TH-expressing neurons was present at birth and continued through P120. This deficit appears selective for the dopaminergic population, because at P21, total neuron number within the SNC, defined as neuronal nuclei protein-positive cells, was not significantly reduced. Interestingly, and similar to observations in PD patients, SNC neuron subpopulations are not equally affected. Calbindin- and calretinin-expressing SNC populations show no significant difference between Wnt-BDNF(KO) mice and controls. Thus, BDNF depletion from the MHB selectively leads to reduced TH expression in a subpopulation of neurons, but it remains unclear whether these cells are lost.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15987955      PMCID: PMC6725062          DOI: 10.1523/JNEUROSCI.4601-04.2005

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  93 in total

1.  The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry.

Authors:  P Damier; E C Hirsch; Y Agid; A M Graybiel
Journal:  Brain       Date:  1999-08       Impact factor: 13.501

2.  Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease.

Authors:  M Mogi; A Togari; T Kondo; Y Mizuno; O Komure; S Kuno; H Ichinose; T Nagatsu
Journal:  Neurosci Lett       Date:  1999-07-23       Impact factor: 3.046

3.  Patterned expression of BDNF and NT-3 in the retina and anterior segment of the developing mammalian eye.

Authors:  J L Bennett; S R Zeiler; K R Jones
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-11       Impact factor: 4.799

4.  Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra.

Authors:  K Parain; M G Murer; Q Yan; B Faucheux; Y Agid; E Hirsch; R Raisman-Vozari
Journal:  Neuroreport       Date:  1999-02-25       Impact factor: 1.837

5.  Differential effects of GDNF and BDNF on cultured ventral mesencephalic neurons.

Authors:  L Feng; C Y Wang; H Jiang; C Oho; K Mizuno; M Dugich-Djordjevic; B Lu
Journal:  Brain Res Mol Brain Res       Date:  1999-03-20

6.  Calretinin and calbindin-D28k in dopaminergic neurons of the rat midbrain: a triple-labeling immunohistochemical study.

Authors:  C Nemoto; T Hida; R Arai
Journal:  Brain Res       Date:  1999-10-30       Impact factor: 3.252

Review 7.  Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests.

Authors:  J N Crawley
Journal:  Brain Res       Date:  1999-07-17       Impact factor: 3.252

8.  The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.

Authors:  P Damier; E C Hirsch; Y Agid; A M Graybiel
Journal:  Brain       Date:  1999-08       Impact factor: 13.501

9.  Targeted inactivation of Hoxb8 affects survival of a spinal ganglion and causes aberrant limb reflexes.

Authors:  E van den Akker; M Reijnen; J Korving; A Brouwer; F Meijlink; J Deschamps
Journal:  Mech Dev       Date:  1999-12       Impact factor: 1.882

10.  Bone morphogenetic protein-2 promotes dissociated effects on the number and differentiation of cultured ventral mesencephalic dopaminergic neurons.

Authors:  J Reiriz; M Espejo; F Ventura; S Ambrosio; J Alberch
Journal:  J Neurobiol       Date:  1999-02-05
View more
  94 in total

Review 1.  Using human pluripotent stem cells to untangle neurodegenerative disease mechanisms.

Authors:  Brigitte Malgrange; Laurence Borgs; Benjamin Grobarczyk; Audrey Purnelle; Patricia Ernst; Gustave Moonen; Laurent Nguyen
Journal:  Cell Mol Life Sci       Date:  2010-10-26       Impact factor: 9.261

2.  Neurogenic potential of progenitor cells isolated from postmortem human Parkinsonian brains.

Authors:  Shanshan Wang; Michael S Okun; Oleg Suslov; Tong Zheng; Nikolaus R McFarland; Vinata Vedam-Mai; Kelly D Foote; Steven N Roper; Anthony T Yachnis; Florian A Siebzehnrubl; Dennis A Steindler
Journal:  Brain Res       Date:  2012-04-27       Impact factor: 3.252

3.  Chronic deprivation of TrkB signaling leads to selective late-onset nigrostriatal dopaminergic degeneration.

Authors:  Maryna Baydyuk; Madeline T Nguyen; Baoji Xu
Journal:  Exp Neurol       Date:  2010-12-28       Impact factor: 5.330

4.  Preventative treatment in an animal model of ADHD: Behavioral and biochemical effects of methylphenidate and its interactions with ovarian hormones in female rats.

Authors:  Jodi L Lukkes; Nadja Freund; Britta S Thompson; Shirisha Meda; Susan L Andersen
Journal:  Eur Neuropsychopharmacol       Date:  2016-07-05       Impact factor: 4.600

5.  Neurotrophin receptor heterozygosity causes deficits in catecholaminergic innervation of amygdala and hippocampus in aged mice.

Authors:  O von Bohlen Und Halbach; L Minichiello
Journal:  J Neural Transm (Vienna)       Date:  2006-06-01       Impact factor: 3.575

6.  Peripheral electrical stimulation reversed the cell size reduction and increased BDNF level in the ventral tegmental area in chronic morphine-treated rats.

Authors:  Ning-Ning Chu; Yan-Fang Zuo; Li Meng; David Yue-Wei Lee; Ji-Sheng Han; Cai-Lian Cui
Journal:  Brain Res       Date:  2007-09-20       Impact factor: 3.252

7.  A comparison of model-based (2D) and design-based (3D) stereological methods for estimating cell number in the substantia nigra pars compacta (SNpc) of the C57BL/6J mouse.

Authors:  Z C Baquet; D Williams; J Brody; R J Smeyne
Journal:  Neuroscience       Date:  2009-04-17       Impact factor: 3.590

Review 8.  Weighing in the role of BDNF in the central control of eating behavior.

Authors:  Joshua Cordeira; Maribel Rios
Journal:  Mol Neurobiol       Date:  2011-10-20       Impact factor: 5.590

9.  Epithelial-derived brain-derived neurotrophic factor is required for gustatory neuron targeting during a critical developmental period.

Authors:  Liqun Ma; Grace F Lopez; Robin F Krimm
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

10.  Assessment of stromal-derived inducing activity in the generation of dopaminergic neurons from human embryonic stem cells.

Authors:  Tandis Vazin; Jia Chen; Chun-Ting Lee; Rose Amable; William J Freed
Journal:  Stem Cells       Date:  2008-04-03       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.